Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

[1]  M. Warmuth,et al.  Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point. , 2015, Cell reports.

[2]  Dennis Carson,et al.  Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers , 2015, PLoS Comput. Biol..

[3]  Wilfried Haerty,et al.  Genome-wide discovery of human splicing branchpoints , 2015, Genome research.

[4]  Caterina Marchiò,et al.  SF3B1 mutations constitute a novel therapeutic target in breast cancer , 2014, The Journal of pathology.

[5]  A. Nicolas,et al.  Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target , 2014, Molecular oncology.

[6]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[7]  Yi Zhang,et al.  Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome , 2014, Nature Structural &Molecular Biology.

[8]  R. Halaban,et al.  Rare SF3B1 R625 mutations in cutaneous melanoma , 2014, Melanoma research.

[9]  S. Roman-Roman,et al.  A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages , 2014, Leukemia.

[10]  Jian Zhang,et al.  Misregulation of pre-mRNA alternative splicing in cancer. , 2013, Cancer discovery.

[11]  David Gentien,et al.  SF3B1 mutations are associated with alternative splicing in uveal melanoma. , 2013, Cancer discovery.

[12]  A. Hinnebusch,et al.  Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 , 2013, Nature Genetics.

[13]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[14]  A. Bowcock,et al.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma , 2013, Nature Genetics.

[15]  J. Valcárcel,et al.  The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.

[16]  E. Giné,et al.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.

[17]  A. Sivachenko,et al.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.

[18]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[19]  H. Tsoi,et al.  Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases. , 2011, Human molecular genetics.

[20]  J. Valcárcel,et al.  Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. , 2011, Genes & development.

[21]  Christopher W. J. Smith,et al.  Genome-Wide Association between Branch Point Properties and Alternative Splicing , 2010, PLoS Comput. Biol..

[22]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[23]  C. Will,et al.  The Spliceosome: Design Principles of a Dynamic RNP Machine , 2009, Cell.

[24]  M. Carmo-Fonseca,et al.  In Vivo Requirement of the Small Subunit of U2AF for Recognition of a Weak 3′ Splice Site , 2006, Molecular and Cellular Biology.

[25]  Andrew M. MacMillan,et al.  Crystal structure of a core spliceosomal protein interface , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[27]  Hiroki Inui,et al.  Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. , 2003, Human molecular genetics.

[28]  Michael R. Green,et al.  Functional recognition of the 3′ splice site AG by the splicing factor U2AF35 , 1999, Nature.

[29]  J. Valcárcel,et al.  Evidence for Substrate-Specific Requirement of the Splicing Factor U2AF35 and for Its Function after Polypyrimidine Tract Recognition by U2AF65 , 1999, Molecular and Cellular Biology.

[30]  Or Gozani,et al.  A Potential Role for U2AF-SAP 155 Interactions in Recruiting U2 snRNP to the Branch Site , 1998, Molecular and Cellular Biology.

[31]  P. Norton,et al.  Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. , 1994, Nucleic acids research.

[32]  J. Valcárcel,et al.  Dual Function for U2AF 35 in AG-Dependent Pre-mRNA Splicing , 2001 .